GlassScriptPhysician profile
Rakesh K Sahni
NPI 1265636526
$14,379.23
in general payments reported to CMS, 2019-2025
52 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,045 · 2020: $591 · 2021: $2,193 · 2022: $4,666 · 2023: $2,489 · 2024: $1,753 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,147 · Travel and Lodging: $709 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,147.24 |
| Travel and Lodging | $708.57 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,551.98 | 2019-2024 | Mitraclip |
| Irhythm Technologies, INC. | $984.37 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $959.91 | 2019-2025 | Wolverine Coronary Cutting Balloon, Guidezilla, Comet |
| Novartis Pharmaceuticals Corporation | $862.01 | 2019-2025 | |
| Novo Nordisk INC | $756.09 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Masimo Corporation | $708.57 | 2023 | Patient Safetynet System, Set and Rainbow Set, Sedline |
| Astrazeneca Pharmaceuticals LP | $700.40 | 2019-2025 | Wainua |
| Amgen INC. | $644.21 | 2020-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $582.92 | 2019-2025 | Lifevest |
| Biotronik INC. | $575.47 | 2020-2025 | Biomonitor, Acticor 7 Vr-T Dx |
| Merck Sharp & Dohme LLC | $457.71 | 2021-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $356.68 | 2019-2025 | |
| Cvrx, INC. | $299.17 | 2022-2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $190.83 | 2019-2023 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $180.38 | 2023-2024 | Inpefa |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $178.34 | 2022-2025 | |
| Daiichi Sankyo INC. | $166.26 | 2021-2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.24 | 2019-2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $145.09 | 2019-2022 | |
| Bardy Diagnostics, INC. | $141.42 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $137.37 | 2021-2023 | Arcalyst |
| Covidien LP | $125.00 | 2019 | |
| Penumbra, INC. | $122.57 | 2024-2025 | Indigo System |
| Baxter Healthcare | $115.10 | 2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $109.45 | 2022-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $108.79 | 2019-2021 | |
| Esperion Therapeutics, INC. | $99.76 | 2020-2024 | Nexletol |
| Heartflow, INC. | $94.22 | 2024-2025 | |
| Astellas Pharma US INC | $77.41 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $70.92 | 2019 | |
| Medtronic, INC. | $70.82 | 2022-2025 | Micra |
| Bard Peripheral Vascular, INC. | $62.61 | 2019-2020 | |
| Shockwave Medical, INC | $56.36 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $54.90 | 2024-2025 | Onpattro |
| Vital Connect, INC | $54.55 | 2025 | Vitalpatch Rtm |
| Abiomed | $46.53 | 2023 | Impella |
| Cardiovascular Systems INC. | $42.07 | 2021 | |
| Scpharmaceuticals INC. | $39.23 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $29.60 | 2019 | |
| Allergan, INC. | $28.85 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $28.78 | 2024 | Arcalyst |
| Medicure Pharma INC. | $28.61 | 2024 | Zypitamag |
| Amryt Pharma Holdings LTD | $27.03 | 2021 | |
| Cashflow Solutions, LLC | $25.92 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Siemens Medical Solutions USA, INC. | $20.85 | 2024 | Acuson Juniper Diagnostic Ultrasound System, Acuson Origin Diagnostic Ultrasound System |
| Qorumpartners | $18.89 | 2022 | |
| Glaxosmithkline, LLC. | $16.99 | 2025 | Arexvy, Shingrix |
| Cleerly, INC. | $15.64 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Opko Pharmaceuticals, LLC | $15.06 | 2022 | |
| Althera Pharmaceuticals LLC | $13.28 | 2021 | |
| Idorsia Pharmaceuticals US INC | $12.82 | 2023 | Quviviq |
| Terumo Medical Corporation | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Sahni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.